Kantarjian H - Search Results

1

Performance of IPSS-M in patients with myelodysplastic syndrome after hypomethylating agent failure.

Urrutia S, Chien KS, Li Z, Bataller A, Almanza E, Sasaki K, Montalban-Bravo G, Short NJ, Jabbour E, Kadia TM, Ravandi F, Borthakur G, Alvarado Y, Daver N, Kanagal-Shamanna R, Bueso-Ramos C, Pierce SA, Kantarjian H, Garcia-Manero G. Urrutia S, et al. Among authors: kantarjian h. Am J Hematol. 2023 Oct;98(10):E281-E284. doi: 10.1002/ajh.27043. Epub 2023 Jul 29. Am J Hematol. 2023. PMID: 37515433 Free article.

2

Treatment of myelodysplastic syndromes with AML-type chemotherapy.

Estey E, Pierce S, Kantarjian H, O'Brien S, Beran M, Andreeff M, Escudier S, Koller C, Kornblau S, Robertson L, et al. Estey E, et al. Among authors: kantarjian h. Leuk Lymphoma. 1993;11 Suppl 2:59-63. doi: 10.3109/10428199309064263. Leuk Lymphoma. 1993. PMID: 7510196 Clinical Trial. No abstract available.

3

Cytogenetic and clinical correlates in AML patients with abnormalities of chromosome 16.

Marlton P, Keating M, Kantarjian H, Pierce S, O'Brien S, Freireich EJ, Estey E. Marlton P, et al. Among authors: kantarjian h. Leukemia. 1995 Jun;9(6):965-71. Leukemia. 1995. PMID: 7596186

4

Immune-mediated and unusual complications during interferon alfa therapy in chronic myelogenous leukemia.

Sacchi S, Kantarjian H, O'Brien S, Cohen PR, Pierce S, Talpaz M. Sacchi S, et al. Among authors: kantarjian h. J Clin Oncol. 1995 Sep;13(9):2401-7. doi: 10.1200/JCO.1995.13.9.2401. J Clin Oncol. 1995. PMID: 7666100 Clinical Trial.

5

Abnormalities in the long arm of chromosome 11 (11q) in patients with de novo and secondary acute myelogenous leukemias and myelodysplastic syndromes.

Cortes J, O'Brien S, Kantarjian H, Cork A, Stass S, Freireich EJ, Keating M, Pierce S, Estey E. Cortes J, et al. Among authors: kantarjian h. Leukemia. 1994 Dec;8(12):2174-8. Leukemia. 1994. PMID: 7808007

6

Clinical and prognostic significance of trisomy 21 in adult patients with acute myelogenous leukemia and myelodysplastic syndromes.

Cortes JE, Kantarjian H, O'Brien S, Keating M, Pierce S, Freireich EJ, Estey E. Cortes JE, et al. Among authors: kantarjian h. Leukemia. 1995 Jan;9(1):115-7. Leukemia. 1995. PMID: 7845005

7

Fludarabine therapy in Waldenström's macroglobulinemia.

Dimopoulos MA, O'Brien S, Kantarjian H, Pierce S, Delasalle K, Barlogie B, Alexanian R, Keating MJ. Dimopoulos MA, et al. Among authors: kantarjian h. Am J Med. 1993 Jul;95(1):49-52. doi: 10.1016/0002-9343(93)90231-d. Am J Med. 1993. PMID: 8328496

8

Result of interferon-alpha therapy in patients with chronic myelogenous leukemia 60 years of age and older.

Cortes J, Kantarjian H, O'Brien S, Robertson LE, Pierce S, Talpaz M. Cortes J, et al. Among authors: kantarjian h. Am J Med. 1996 Apr;100(4):452-5. doi: 10.1016/s0002-9343(97)89522-8. Am J Med. 1996. PMID: 8610733 Clinical Trial.

9

Topotecan, a topoisomerase I inhibitor, is active in the treatment of myelodysplastic syndrome and chronic myelomonocytic leukemia.

Beran M, Kantarjian H, O'Brien S, Koller C, al-Bitar M, Arbuck S, Pierce S, Moore M, Abbruzzese JL, Andreeff M, Keating M, Estey E. Beran M, et al. Among authors: kantarjian h. Blood. 1996 Oct 1;88(7):2473-9. Blood. 1996. PMID: 8839838 Free article. Clinical Trial.

10

Treatment of newly diagnosed acute promyelocytic leukemia without cytarabine.

Estey E, Thall PF, Pierce S, Kantarjian H, Keating M. Estey E, et al. Among authors: kantarjian h. J Clin Oncol. 1997 Feb;15(2):483-90. doi: 10.1200/JCO.1997.15.2.483. J Clin Oncol. 1997. PMID: 9053469 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,548 results

Search Page

Filters